Indus Capital Partners, LLC Next Cure, Inc. Transaction History

Indus Capital Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$21.19 - $40.2 $2.01 Million - $3.81 Million	-94,699 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$32.32 - $58.37 $1.83 Million - $3.31 Million	56,750 Added 149.54%	94,699 $3.51 Million
Q4 2019 Feb 14, 2020	SELL	$25.0 - $92.22 $411,300 - $1.52 Million	-16,452 Reduced 30.24%	37,949 $2.14 Million
Q3 2019 Nov 14, 2019	SELL	$15.73 - $41.6 $1.48 Million - $3.91 Million	-93,946 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$14.16 - $20.64 $1.33 Million - $1.94 Million	93,946 New	93,946 $1.41 Million

16.1M

10.5K

Ticker NXTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,748,800
Market Cap $42.5M
Description
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...

Get notified when there are updates to the investment portfolio of Indus Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Indus Capital Partners, LLC with notifications on news.